DAXOR CORP

Regulatory Filings • May 16, 2017

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

| | OMB
APPROVAL |
| --- | --- |
| UNITED
STATES SECURITIES AND EXCHANGE COMMISSION Washington,
D.C. 20549 | OMB
Number: 3235-0060 Expires: March 31, 2018 Estimated average burden hours per response……..5.71 |

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) 5/16/2017

| Daxor
Corporation |
| --- |
| (Exact
name of registrant as specified in its charter) |

| New
York | 0-12248 | 13-2682108 |
| --- | --- | --- |
| (State
or other jurisdiction | (Commission | (IRS
Employer |
| of
incorporation) | File
Number) | Identification
No.) |

| 350
5 th Avenue, New York New York | 10118 |
| --- | --- |
| (Address
of principal executive offices) | (Zip
Code) |

212-330-8500
Registrant’s
telephone number, including area code

Field: Rule-Page

Field: /Rule-Page

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

| [ ] | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| [ ] | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 5.05 - On May 10, 2017 Eric Coleman, Chief Financial Officer, was released from Daxor Corporation's employ. On Monday, May 15, 2017, John Wilkens assumed the role of Daxor's Chief Financial Officer.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

| | DAXOR
CORPORATION | |
| --- | --- | --- |
| | (Registrant) | |
| Date:
May 15, 2017 | By: | /s/
Diane Meegan |
| | Name: | Diane Meegan |
| | Title: | Corporate Secretary |

Field: Page; Sequence: 3

Field: /Page